Search

everythinglearnresearchcommunity

for

Search:↓

Pregnancy can cause normal skin changes that usually go away after childbirth and don't need treatment.

PFS and PSSD are similar conditions with persistent sexual dysfunction after stopping medication.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Testosterone therapy is beneficial for women's health and does not cause masculinization or liver damage, and it protects the heart and breasts.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Women with polycystic ovary syndrome tend to have a longer anogenital distance.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Woodhouse-Sakati syndrome often causes sexual development issues, hair loss, learning disabilities, deafness, muscle contractions, limb pain, and diabetes.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Laser treatments are the most effective for porokeratotic adnexal ostial nevus.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

A young woman's Cronkhite-Canada syndrome improved on its own after she gave birth.

No link found between specific genes and female pattern hair loss.

Women experience various skin issues at different life stages, requiring careful treatment and awareness.

Genetic counselors should be culturally skilled and aware of transgender patients' unique health risks and needs.

Demodex mites rarely cause scalp infections leading to hair loss, but when they do, treatment is effective.

Mice lacking steroid 5α-reductase 2 show less aggression and better impulse control.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.

Minoxidil effectively promotes hair regrowth in younger patients with small balding areas.

A postmenopausal woman's hair loss and excess hair growth improved after surgery for ovarian hyperthecosis.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The conclusion is that managing cholesterol is important for women, especially during pregnancy, breastfeeding, and with PCOS, and involves regular screening and careful treatment choices.

People with first-time vitiligo have lower levels of a certain brain protein compared to healthy individuals.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.